Paper17545978
Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)--a general method for mapping sites of probe modification in proteomes.
Weerapana E and 2 others. Nat Protoc, 2007. Cited by 224 papers, by iCite.
Cite this record
ConductScience Library. Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)--a general method for mapping sites of probe modification in proteomes. Papers, record 17545978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17545978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)--a general method for mapping sites of probe modification in proteomes.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Profiling | Major topic |
| Molecular Probes | Major topic |
| Proteome | Major topic |
| Animals | |
| Biotin | |
| Mice | |
| Myocardium | |
| Protein Conformation | |
| Proteomics |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA087660 | NCI NIH HHS | United States | R01CA087660 | PubMed and NIH |
Source NIH RePORTER
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 224 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964996 | Ninhydrin as a Covalent Warhead for Chemical Proteomic-Enabled Discovery and Selective Engagement of Reactive Arginines. | ACS Cent Sci | 2026 | https://conductscience.org/library/papers/42964996 | PubMed |
| 42606932 | Protocol for covalent ligand discovery via library-versus-proteome screening. | STAR Protoc | 2026 | https://conductscience.org/library/papers/42606932 | PubMed |
| 42420309 | A NIR fluorotag reporter CETIF6a enables bright pan-tumor labeling and functional proteomic profiling. | Nat Commun | 2026 | https://conductscience.org/library/papers/42420309 | PubMed |
| 42321189 | Scaling covalent ligand discovery through dynamic combinatorial library-versus-proteome screening. | Nat Commun | 2026 | https://conductscience.org/library/papers/42321189 | PubMed |
| 42098112 | Triose phosphate isomerase 1 remodels mitochondrial cristae ultrastructure to rewire microglial immunometabolism against ischemic stroke. | Nat Commun | 2026 | https://conductscience.org/library/papers/42098112 | PubMed |
| 41546417 | Chemical Proteomics Identifies Ketogenesis-Mediated Cysteine Modifications Regulating Redox Function. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/41546417 | PubMed |
| 41501555 | Biocompatible ligand balancing in transition metal coordination enables benign in-cell protein arylation. | Nat Chem | 2026 | https://conductscience.org/library/papers/41501555 | PubMed |
| 41482574 | Global profiling of arginine reactivity and ligandability in the human proteome. | Nat Chem | 2026 | https://conductscience.org/library/papers/41482574 | PubMed |
| 41463355 | Targeting the Reactive Proteome: Recent Advances in Activity-Based Protein Profiling and Probe Design. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463355 | PubMed |
| 41315240 | Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation. | Nat Commun | 2025 | https://conductscience.org/library/papers/41315240 | PubMed |
| 41255992 | Illuminating the Druggable Human Proteome with an AI Protein Profiling Platform. | Res Sq | 2025 | https://conductscience.org/library/papers/41255992 | PubMed |
| 41091880 | Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma. | Sci Adv | 2025 | https://conductscience.org/library/papers/41091880 | PubMed |
| 40964370 | Illuminating the Druggable Human Proteome with an AI Protein Profiling Platform. | bioRxiv | 2025 | https://conductscience.org/library/papers/40964370 | PubMed |
| 40578074 | Recent advances in chemical proteomics for protein profiling and targeted degradation. | Curr Opin Chem Biol | 2025 | https://conductscience.org/library/papers/40578074 | PubMed |
| 40404146 | Advancing Covalent Ligand and Drug Discovery beyond Cysteine. | Chem Rev | 2025 | https://conductscience.org/library/papers/40404146 | PubMed |
| 39803451 | Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma. | bioRxiv | 2024 | https://conductscience.org/library/papers/39803451 | PubMed |
| 39290210 | Improved deconvolution of natural products' protein targets using diagnostic ions from chemical proteomics linkers. | Beilstein J Org Chem | 2024 | https://conductscience.org/library/papers/39290210 | PubMed |
| 39139999 | Baicalin reduces chronic stress-induced breast cancer metastasis via directly targeting β2-adrenergic receptor. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39139999 | PubMed |
| 39052621 | Dual-Probe Activity-Based Protein Profiling Reveals Site-Specific Differences in Protein Binding of EGFR-Directed Drugs. | ACS Chem Biol | 2024 | https://conductscience.org/library/papers/39052621 | PubMed |
| 38925478 | Proteomic strategies to interrogate the Fe-S proteome. | Biochim Biophys Acta Mol Cell Res | 2024 | https://conductscience.org/library/papers/38925478 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17545978
GET https://conductscience.org/api/papers/v1/17545978/cited_by?page=2